- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Deutsch
- Erschienen in
-
Juvenile Uveitis ; volume:38 ; number:5 ; day:27 ; month:2 ; year:2024 ; pages:191-208 ; date:10.2024
Spektrum der Augenheilkunde ; 38, Heft 5 (27.2.2024), 191-208, 10.2024
- Schlagwort
-
Uveitis
Kind
Augenkrankheit
Intermediäre Uveitis
- Urheber
-
Eidherr, Markus
Jarz-Lackner, Hildrun
Bolz, Matthias
Barisani-Asenbauer, Talin
Strauß, Rupert W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00717-023-00567-8
- URN
-
urn:nbn:de:101:1-2501061035262.942244972934
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eidherr, Markus
- Jarz-Lackner, Hildrun
- Bolz, Matthias
- Barisani-Asenbauer, Talin
- Strauß, Rupert W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Juvenile idiopathic arthritis-associated uveitis
Juvenile Spondyloarthritis: focus on uveitis
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Juvenile idiopathic arthritis-associated uveitis
Juvenile Spondyloarthritis: focus on uveitis
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Juvenile idiopathic arthritis-associated uveitis
Juvenile Spondyloarthritis: focus on uveitis
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy